GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cdk1 | decreases activity | EXP | | 6480464 | CTD | Sirolimus results in decreased activity of CDK1 protein | PMID:7532117 | Cdk1 | decreases activity | ISO | Cdk1 (Mus musculus) | 6480464 | CTD | Sirolimus results in decreased activity of CDK1 protein | PMID:7503980 | Cdk1 | decreases expression | ISO | CDK1 (Homo sapiens) | 6480464 | CTD | Sirolimus results in decreased expression of CDK1 | PMID:8419408 | Cdk1 | decreases expression | ISO | Cdk1 (Mus musculus) | 6480464 | CTD | Sirolimus results in decreased expression of CDK1 mRNA; Sirolimus results in decreased expression of CDK1 protein | PMID:19922502 | Cdk1 | multiple interactions | ISO | CDK1 (Homo sapiens) | 6480464 | CTD | [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of CDK1 mRNA; [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of CDK1 protein; [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased phosphorylation of CDK1 protein; [fulvestrant co-treated with Sirolimus] results in decreased expression of CDK1 mRNA | PMID:15767555 PMID:19016759 PMID:19223503 | Cdk1 | multiple interactions | ISO | Cdk1 (Mus musculus) | 6480464 | CTD | Sirolimus inhibits the reaction [IL2 protein results in increased expression of CDK1 mRNA] | PMID:11355896 | |
Go Back to source page | Continue to Ontology report |